Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Institutional Review Board of Franciscan Health Lafayette
EIR
•Institutional Review Board of Franciscan Health Lafayette•October 18, 2017

Institutional Review Board of Franciscan Health Lafayette – FDA EIR, Oct 18, 2017

Record Details

An FDA inspection of the Institutional Review Board of Franciscan Health Lafayette in Lafayette, IN, was conducted from October 10-18, 2017. This directed follow-up inspection, conducted under the regulatory guidance of CPGM 7348.809 for Institutional Review Boards, aimed to assess corrective actions from previous observations.

The main violation identified was a repeat deficiency: the failure to conduct continuing review of research studies at intervals of not less than once per year, citing three specific studies. This finding reiterates a non-compliance with 21 CFR 56.109(f), which was also observed in prior inspections concluding in December 2014 and February 2013, each resulting in an FDA 483 and/or Untitled Letters. While an earlier issue regarding the maintenance of comprehensive IRB member rosters had been successfully addressed, the critical lapse in annual research review persisted despite previous commitments for corrective measures.

In response to the current observations, the IRB committed to providing a detailed corrective action plan within 15 business days. Additionally, management revealed intentions to centralize IRB review functions within the broader Franciscan Alliance system by January 2018, aiming for enhanced system-wide oversight and compliance.

Company
Institutional Review Board of Franciscan Health Lafayette
Inspection date
October 18, 2017
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Jason J. Cerman (company_representative)
  • Terrence J. Wilson (company_representative)
  • Thomas J. Gryzbek (company_representative)
  • Elizabeth A. Glowinski (company_representative)
  • Myra K. Casey (U.S. Food and Drug Administration)
View Company Profile

ID · 7b37b836-934e-435c-9a4e-5dd5b89881f5

Violation Codes2
21 CFR 56.109(f)21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Institutional Review Board of Franciscan Health Lafayette
  • EIR - 2013-02-13February 13, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Institutional Review Board of Franciscan Health Lafayette
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.